Immuneering Corp Financials
| IMRX Stock | USD 1.80 0.15 9.09% |
Immuneering |
Understanding current and past Immuneering Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Immuneering Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Immuneering Corp's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Immuneering Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Immuneering Corp. Check Immuneering Corp's Beneish M Score to see the likelihood of Immuneering Corp's management manipulating its earnings.
Immuneering Corp Stock Summary
Immuneering Corp competes with Pmv Pharmaceuticals, Cullinan Oncology, Enliven Therapeutics, Larimar Therapeutics, and Centessa Pharmaceuticals. Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited. Immuneering Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US45254E1073 |
| CUSIP | 45254E107 |
| Location | Massachusetts; U.S.A |
| Business Address | 245 Main Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | immuneering.com |
| Phone | 617 500 8080 |
| Currency | USD - US Dollar |
Immuneering Corp Key Financial Ratios
Immuneering Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Immuneering Corp's current stock value. Our valuation model uses many indicators to compare Immuneering Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immuneering Corp competition to find correlations between indicators driving Immuneering Corp's intrinsic value. More Info.Immuneering Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immuneering Corp's earnings, one of the primary drivers of an investment's value.Immuneering Corp Systematic Risk
Immuneering Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Immuneering Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Immuneering Corp correlated with the market. If Beta is less than 0 Immuneering Corp generally moves in the opposite direction as compared to the market. If Immuneering Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Immuneering Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Immuneering Corp is generally in the same direction as the market. If Beta > 1 Immuneering Corp moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Immuneering Corp is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Immuneering has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Immuneering Corp's financials are consistent with your investment objective using the following steps:- Review Immuneering Corp's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Immuneering Corp's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Immuneering Corp's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Immuneering Corp's stock is overvalued or undervalued.
Immuneering Corp March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Immuneering Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Immuneering Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immuneering Corp based on widely used predictive technical indicators. In general, we focus on analyzing Immuneering Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immuneering Corp's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 22.13 | |||
| Value At Risk | (4.52) | |||
| Potential Upside | 4.95 |
Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.